Cardiac Arrhythmia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years. 2. Patients with atrial fibrillation/atrial flutter/atrial tachycardia or idiopathic ventricular arrhythmia. 3. Ablation procedures planned to be performed in a radiation-free catheter lab using Carto system-related technology. 4. Participate in this study voluntarily and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. With severe disease and expected survival of less than one year. 2. History of myocardial infarction, coronary artery bypass transplantation and percutaneous coronary intervention within 3 months. 3. Inner diameter of left chamber is greater than 50mm. 4. Ultrasonography indicated left ventricular ejection fraction < 40%. 5. NYHA cardiac function grade III or IV. 6. Heart or vascular malformations are not conducive to catheter surgery or vascular puncture. 7. Vulnerable groups, including persons with mental illness, persons with cognitive impairment, pregnant women, illiterates, etc. 8. Patients are known to be unable to complete postoperative follow-up. 9. Participating in or planning to participate in other interventional clinical studies during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No recurrence of arrhythmias occurred without antiarrhythmic drugs 3 to 12 months after the first ablation;Procedure-related serious adverse events; | — |
Countries
China
Contacts
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University